ImmuPharma Plc (LON:IMM) Chairman Tim McCarthy talks with DirectorsTalk about the phase 3 trials of lupuzor being opened up to Mauritius. Tim explains why the site is being opened up, how this fits in with the timeline, the request by the Government and Lupus Alert to open up the trial and key milestones for the company going forward.